Aspect Analytics

Aspect Analytics is a computational spatial biology company that develops the Weave® software platform, purpose-built to transform complex spatial and multimodal biological data into actionable insights for drug discovery and development. By integrating spatial transcriptomics, proteomics, metabolomics, mass spectrometry imaging (MSI), histology, and digital pathology into a unified analytical framework, Weave enables scientists to understand how cells, molecular states, and tissue architecture interact at single-cell resolution and at enterprise scale.

The company serves pharmaceutical organizations, contract research organizations (CROs), and academic research institutes, and has engaged with multiple top-20 pharmaceutical companies. Aspect Analytics combines deep expertise in spatial biology, bioinformatics, AI/ML, and enterprise software engineering, and has co-published research with partners including GSK, Merck, and Boehringer Ingelheim. The company is backed by investors Capricorn Partners and PMV, and maintains verified interoperability with leading platforms including Bruker, 10x Genomics, Standard BioTools, and BioTechne (Lunaphore).

Weave® Platform — Core Capabilities

• Multimodal data harmonization: Fuse spatial, molecular, and metadata from diverse assay types — including spatial transcriptomics, proteomics, metabolomics, lipidomics, glycomics, MSI, multiplexed fluorescence microscopy, and histology — into a shared reference framework with modality-specific accuracy down to single-cell resolution.
• Cellular neighborhood and tissue structure analysis: Interrogate cell–cell interactions, cell states, and tissue architecture to reveal disease mechanisms and therapeutic responses that are only visible in multicellular spatial context. Aspect Analytics holds patented methods for integrating spatial omics and MSI data for this purpose.
• Cohort-level analysis: Compare tissues, conditions, and patient groups using reproducible, governed workflows that preserve spatial relationships and cellular neighborhoods, enabling insights that scale beyond individual samples or studies.
• AI-ready data management: Generate structured, lineage-tracked datasets that are measurable, interpretable, and indexable, ready for training and deploying machine learning models and supporting large-scale analysis.
• Enterprise-scale architecture: Run standardized, reproducible, and auditable pipelines across teams and sites. Automate and enhance data analyses through domain-specific agentic workflows.
• Flexible access: Interact with Weave through an intuitive user interface, software development kits (SDKs), and APIs, enabling both bench scientists and computational teams to work within the same governed environment.
• Cross-disciplinary collaboration: Bring biology, pathology, computational, and AI teams together on shared, governed datasets to enable reproducible end-to-end workflows without switching tools or rebuilding pipelines.

Key Shifts Weave Enables

• From disconnected omics layers to coherent spatial context: Integrate spatial, molecular, and metadata into a unified reference framework with single-cell precision.
• From isolated sample viewers to cohort-level understanding: Apply reproducible workflows that preserve spatial relationships across tissues, conditions, and patient groups.
• From manual pipelines to structured, AI-ready data: Make cellular neighborhoods measurable and indexable through lineage-tracked datasets ready for modeling.
• From individual studies to cumulative knowledge: Reuse data, preserve provenance, and build on prior analyses across programs to accelerate discovery and reduce rework.

Drug Discovery and Development Solutions

• Target Discovery and Validation: Uncover and validate cellular drivers and mechanistic signatures by integrating histology with spatial molecular assays.
• Mechanism of Action (Preclinical): Connect phenotype to pathway activity, signaling changes, cell–cell interactions, and cellular neighborhoods.
• PK/PD and Drug Distribution: Quantify drug compound effects by combining MSI-based compound localization with molecular expression data and tissue architecture.
• Clinical Research and Stratification: Integrate biomarker data, imaging, and spatial molecular profiles to refine patient cohorts and support medical strategy.

Who Weave Serves

• Pharmaceutical companies: Unlock novel insights, validate hypotheses with orthogonal evidence, and shorten time-to-insight for faster, data-driven decisions.
• Contract Research Organizations (CROs): Deliver standardized, high-value analyses with traceable outputs to sponsors.
• Research institutes: Build and manage FAIR, shareable datasets that reveal novel insights and accelerate collaboration and publication.

Scientific Services

• Aspect Analytics offers specialized scientific and computational services to complement the Weave platform, helping customers extract more value from spatial and multimodal data while building long-term internal independence.
• Services are adaptable to customer needs, including pilot project support, deep multimodal data interpretation, and personalized workflow development directly inside Weave.
• Customers can choose to outsource specific analyses, collaborate closely with Aspect Analytics experts, or use Weave independently through guided enablement and training programs.

Scientific and Technical Leadership

• The team has pioneered advances across spatial omics (transcriptomics, proteomics, metabolomics, lipidomics, glycomics), imaging modalities (MSI, multiplexed fluorescence microscopy, histology, digital pathology), and computation (machine learning, deep learning, data pipelines, high-dimensional analysis).
• Aspect Analytics holds patented algorithms and advanced co-registration technology, positioning the company as a recognized leader in multicellular environment analysis and tissue-level mechanism discovery.
• Joint publications with GSK, Merck, and Boehringer Ingelheim demonstrate the platform's application to real-world drug discovery challenges, including deep learning-based spatial clustering of MSI data and quantitative lipid imaging in brain tissue.

Aspect Analytics is committed to building an open, vendor-neutral spatial biology ecosystem. Through its partnerships with leading instrument and platform providers, its investor-backed growth, and its mission to make spatial biology accessible, integrated, and reusable, the company is establishing the computational foundation for the next generation of spatially informed drug discovery and development.